Prostate cancer (PCa) is a leading cause of death in the male population commonly treated
with androgen deprivation therapy that often relapses as androgen-independent and …

Prostate cancer (PCa) is a non-cutaneous malignancy in males with wide variation in
incidence rates across the globe. It is the second most reported cause of cancer death. Its …

Fibroblast growth factor receptor 1 (FGFR1) is a core component of the FGFs/FGFR pathway
that activates multiple signalling pathways, including ERK1/2, PI3K/AKT, PLCγ, and NF-κB …

Abstract Fibroblast growth factor 2 (FGF2) plays an important role in tumor angiogenesis.
Humanized disulfide‐stable double‐chain antibody against fibroblast growth factor‐2 (anti …

FGF10, as an FGFR2b-specific ligand, plays a crucial role during cell proliferation, multi-
organ development, and tissue injury repair. The developmental importance of FGF10 has …

Ocular tumors are a family of rare neoplasms that develop in the eye. Depending on the type
of cancer, they mainly originate from cells localized within the retina, the uvea, or the …

Angiogenesis in metastatic castration-resistant prostate cancer (mCRPC) has been
extensively investigated as a promising druggable biological process. Nonetheless …

Background The medical therapy of prostatic symptoms (MTOPS) trial randomized men with
symptoms of benign prostatic hyperplasia (BPH) and followed response of treatment with a …

Prostate cancer (PCa) is a leading cause of cancer mortality in the male population
commonly treated with androgen deprivation therapy (ADT) and relapsing as aggressive …

Aberrations in the fibroblast growth factor receptor2 (FGFR2) gene, including genetic
alterations and chromosomal rearrangements, lead to the development and progression of …